INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
GA

Garofalo Elizabeth A.

DirectorCIK 0001826361

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 0
Max Insider Score17
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
GA
Garofalo Elizabeth A.Director
ACADACADIA PHARMACEUTICALS INC
Grant or award
A—
16.0K sh
May 29, 2026Jun 1, 2026
traded May 29, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    ACADIA PHARMACEUTICALS INCDirector · Jun 1, 2026
9
GA
Garofalo Elizabeth A.Director
ACADACADIA PHARMACEUTICALS INC
Grant or award
A
—
9,311 sh
May 29, 2026
Jun 1, 2026
traded May 29, 2026
+3d
SEC FORM 4

Evidence

9
GA
Garofalo Elizabeth A.Director
ACADACADIA PHARMACEUTICALS INC
Option exercise
M—
8,107 sh
May 29, 2026Jun 1, 2026
traded May 29, 2026
+3dSEC FORM 4

Evidence

17
GA
Garofalo Elizabeth A.Director
ACADACADIA PHARMACEUTICALS INC
Option exercise
M—
8,107 sh
May 29, 2026Jun 1, 2026
traded May 29, 2026
+3dSEC FORM 4

Evidence